Hayat Pharmaceutical Industries Faces Evaluation Adjustment Amid Declining Sales and Profitability Challenges

Sep 02 2025 03:56 PM IST
share
Share Via
Hayat Pharmaceutical Industries Co. has recently experienced a score revision, influenced by various market trends and metrics. In the latest quarter, the company reported a decline in net sales and profit, alongside challenges in managing receivables, while still maintaining a positive return on equity and stock performance over the past year.
Hayat Pharmaceutical Industries Co. has recently undergone an evaluation adjustment, reflecting a revision in its score. This adjustment comes in light of various underlying trends and metrics that characterize the company's current market position.

In the latest quarter ending June 2025, Hayat reported net sales of JOD 3.37 million, which indicates a notable decline of 20.69% compared to previous periods. Additionally, the net profit for the same quarter was JOD 0.35 million, marking a significant decrease of 55.79%. The company's debtors turnover ratio has reached a low of 1.57, suggesting challenges in managing receivables effectively.

Despite these figures, Hayat maintains a return on equity (ROE) of 10.24%, which points to an attractive valuation, particularly with a price-to-book value of 0.00. Over the past year, the stock has generated a return of 20.40%, while profits have increased by 30.6%, indicating some resilience in its overall performance.

This evaluation adjustment reflects the complexities of Hayat Pharmaceutical Industries Co.'s current standing in the pharmaceuticals and biotechnology sector.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News